Compare COCH & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COCH | ZTEK |
|---|---|---|
| Founded | 1995 | 2008 |
| Country | United States | Canada |
| Employees | 47 | N/A |
| Industry | Blank Checks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.7M | 51.8M |
| IPO Year | N/A | 2022 |
| Metric | COCH | ZTEK |
|---|---|---|
| Price | $0.70 | $0.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 738.0K | 272.8K |
| Earning Date | 05-08-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.58 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $0.37 |
| 52 Week High | $1.89 | $1.24 |
| Indicator | COCH | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 48.72 | 48.12 |
| Support Level | $0.64 | $0.46 |
| Resistance Level | $0.74 | $0.55 |
| Average True Range (ATR) | 0.09 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 22.33 | 49.79 |
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.